Clinical Trials Sponsored by Xu Lei

Total 5924 results

LEO Pharma

Completed

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

United States
LEO Pharma

Completed

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
LEO Pharma

Completed

LEO 90100 in the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

United States
LEO Pharma

Completed

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Actinic Keratosis

Canada, Germany, Australia, France, United Kingdom
LEO Pharma

Completed

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Germany
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds

Psoriasis Vulgaris

United Kingdom, France, Canada
LEO Pharma

Completed

A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

Psoriasis Vulgaris

France
LEO Pharma

Completed

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

Scalp Psoriasis

China
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

Canada, United Kingdom, France
LEO Pharma

Completed

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Psoriasis Vulgaris

United States
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Psoriasis of Scalp

Canada, Denmark, France, Germany, United Kingdom
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Psoriasis of Scalp

Canada, Belgium, Finland, France, Germany, Netherlands, United Kingdom
LEO Pharma

Completed

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

France
LEO Pharma

Completed

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

Psoriasis Vulgaris

France
LEO Pharma

Completed

Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

Multiple Myeloma
LEO Pharma

Completed

LEO19123 Cream in the Treatment of Hand Eczema

Hand Eczema

United Kingdom
LEO Pharma

Terminated

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Liver Neoplasms

Spain, Canada, France, Italy, United Kingdom
Zhang Lei

Recruiting

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Zhang Lei

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Thrombocytopenia | Splenectomy

China
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company; Genentech, Inc.

Terminated

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company; Aventis Pharmaceuticals

Completed

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Douglas Mental Health University Institute
Réseau québécois sur le suicide, les troubles de l'humeur et les troubles...

Completed

Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression

Depressive Disorder, Major | Depressive Disorder, Treatment-Resistant | Unipolar Depression | Depression, Bipolar

Canada
Institut de Recherche Clinique sur les Cancers...
Pfizer

Completed

Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

Metastatic Colorectal Cancer

France
Zhang Lei, MD

Recruiting

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Thrombocytopenia | Antiphospholipid Syndrome | Treatment

China
LEO Pharma
Bayer

Completed

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
MEI Pharma, Inc.

Terminated

A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's Lymphoma

United States, Switzerland
LEO Pharma
Bayer

Completed

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

Germany
LEO Pharma
Bayer

Completed

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen (OLEA)

Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen

Spain
Laboratorios Leti, S.L.

Completed

To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.

Allergy to Pollen

Spain
Laboratorios Leti, S.L.

Completed

To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.

Allergy to Alternaria Fungus

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Lolium Perenne Allergen Extract

Allergy to Grass Pollen

Spain
Laboratorios Leti, S.L.

Completed

Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Spain
Laboratorios Leti, S.L.

Completed

Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)

Allergy | Rhinoconjunctivitis

Spain
MEI Pharma, Inc.

Completed

A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

Prostate Cancer

United States
Clinact
LEO Pharma

Completed

Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients (PSO-TARGET)

Psoriasis

France, Belgium
MEI Pharma, Inc.

Terminated

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)

United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
LEO Pharma
Bayer

Completed

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
LEO Pharma
Bayer

Completed

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Skin Mycoses

Russian Federation
LEO Pharma
Bayer

Completed

An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids (Ointment TS-AD)

Dermatitis, Atopic

Japan
Les Grands Prés

Unknown

Central Apnea in Patients Receiving Ticagrelor

Acute Coronary Syndrome

France
Laboratorios Leti, S.L.

Completed

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Asthma | Rhinitis | Rhinoconjunctivitis

Spain
Peplin
LEO Pharma

Completed

PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects

Healthy | Actinic Keratosis

United States
Lee, Steven, M.D.

Completed

Refraction Determination Analysis

Myopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
Laboratorios Leti, S.L.

Completed

Biological Standardization of Chenopodium Album Allergen Extract

Allergy to Chenopodium Album

Spain
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Poa Pratensis Allergen Extract

Allergy to Grass Pollen

Spain

3

Subscribe